Published in Eur Heart J on March 01, 2004
Clinical importance of aspirin and clopidogrel resistance. World J Cardiol (2010) 0.95
Clopidogrel in acute coronary syndrome: when, how much, how long? Z Kardiol (2005) 0.86
Aspirin and clopidogrel response variability: review of the published literature. Tex Heart Inst J (2008) 0.84
Antiplatelet resistance and the role of associated variables in stable patients treated with stenting. Postepy Kardiol Interwencyjnej (2015) 0.78
Antiplatelet Resistance-Does it Exist and How to Measure it? Clin Med Cardiol (2009) 0.78
Are we making efficient use of clopidogrel? Eur Heart J (2004) 0.77
Risk factors for clopidogrel resistance in patients with ischemic cerebral infarction and the correlation with ABCB1 gene rs1045642 polymorphism. Exp Ther Med (2014) 0.76
Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study. Br J Clin Pharmacol (2016) 0.75
Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis. PLoS One (2011) 0.75
Oral antiplatelet therapy and platelet inhibition: An experience from a tertiary care center. Indian Heart J (2016) 0.75
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J (2011) 1.98
Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratories. Clin Chem (2013) 1.58
Increased platelet-collagen interaction associated with double homozygosity for receptor polymorphisms of platelet GPIa and GPIIIa. Arterioscler Thromb Vasc Biol (2002) 1.38
Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass. Ann Thorac Surg (2008) 1.38
Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients. Thromb Haemost (2006) 1.07
Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb Res (2010) 1.01
Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity. Arterioscler Thromb Vasc Biol (2002) 0.99
Platelet ligands and ADAMTS13 during Puumala hantavirus infection and associated thrombocytopenia. Blood Coagul Fibrinolysis (2011) 0.94
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors. N Engl J Med (2011) 0.92
Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysis. Semin Thromb Hemost (2012) 0.90
No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg (2003) 0.90
Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs. Obesity (Silver Spring) (2011) 0.88
Thrombophilia and arteriovenous fistula survival in ESRD. Clin J Am Soc Nephrol (2013) 0.87
New insights into von Willebrand disease and platelet function. Semin Thromb Hemost (2012) 0.86
Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome. J Cardiothorac Vasc Anesth (2006) 0.85
Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease. Liver Int (2010) 0.85
Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal women. Menopause (2003) 0.85
Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease. Thromb Haemost (2009) 0.84
Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor. Thromb Res (2009) 0.84
Risk of thromboembolism in 14,000 individuals with coeliac disease. Br J Haematol (2007) 0.84
Unaltered blood coagulation and platelet function in healthy subjects exposed to acute hypoxia. Aviat Space Environ Med (2011) 0.83
Thrombin in myocardial ischemia-reperfusion during cardiac surgery. Ann Thorac Surg (2009) 0.82
Carotid plaque mast cells associate with atherogenic serum lipids, high grade carotid stenosis and symptomatic carotid artery disease. Results from the helsinki carotid endarterectomy study. Cerebrovasc Dis (2005) 0.82
Interaction between clinic and laboratory. Thromb Res (2011) 0.81
Parvovirus transmission by blood products - a cause for concern? Br J Haematol (2012) 0.81
Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects. Br J Clin Pharmacol (2013) 0.80
Alterations of sympathetic nervous system, coagulation and platelet function in gestational diabetes. Blood Coagul Fibrinolysis (2012) 0.80
Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays. Thromb Haemost (2008) 0.80
Association of the fibrinolytic system and hemorheology with symptoms in patients with carotid occlusive disease. Cerebrovasc Dis (2005) 0.79
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial. EuroIntervention (2015) 0.79
Platelet deposition on stainless steel, spiral, and braided polylactide stents. A comparative study. Thromb Haemost (2004) 0.78
D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity. Neurosurgery (2005) 0.78
Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: retrospective analysis of safety profile and effect on blood coagulation. Scand J Urol (2013) 0.77
Activation of protein C and hemodynamic recovery after coronary artery bypass surgery. J Thorac Cardiovasc Surg (2007) 0.77
Laboratory-monitored fondaparinux and coagulation activity in association with total hip replacement. Blood Coagul Fibrinolysis (2014) 0.77
Comparison of monitoring methods for lepirudin: impact of warfarin and lupus anticoagulant. Thromb Res (2010) 0.76
Platelet responses and coagulation activation on polylactide and heparin-polycaprolactone-L-lactide-coated polylactide stent struts. J Biomed Mater Res A (2003) 0.75
Inhibitor development in non-severe haemophilia across Europe. Thromb Haemost (2015) 0.75
Elevated thrombopoietin and platelet indices confirm active thrombopoiesis but fail to predict clinical severity of puumala hantavirus infection. Medicine (Baltimore) (2016) 0.75
[Liver disease and hemostasis--evaluation of bleeding risk]. Duodecim (2012) 0.75
[Aplasia of the inferior vena cava as a cause of recurring thrombosis in a young man]. Duodecim (2004) 0.75
Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists. Thromb Res (2006) 0.75
Thrombophilia: a new potential risk factor for cervical insufficiency. Thromb Res (2006) 0.75
Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans. Thromb Haemost (2016) 0.75
[Is the D-dimer test a blessing or a headache for clinicians?]. Duodecim (2004) 0.75
Budd-Chiari syndrome in a young female with factor V Leiden mutation: successful treatment with lepirudin, a direct thrombin inhibitor. Thromb Res (2007) 0.75
Urokinase, tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis. Blood Coagul Fibrinolysis (2003) 0.75
[Antithrombotic medication of cardiac patient in connection with surgery and minor operations]. Duodecim (2009) 0.75
Platelet microparticle suppressing antibody against GP Ibalpha acts independently of the filamin cleavage and increases protein tyrosine phosphorylation. Blood Coagul Fibrinolysis (2008) 0.75
[Chronic liver disease and thrombosis risk]. Duodecim (2015) 0.75
Increased preoperative thrombin generation and low protein S level associated with unfavorable postoperative hemodynamics after coronary artery bypass grafting. Perfusion (2010) 0.75
A direct thrombin inhibitor, lepirudin, for thrombophilic patients with inoperable critical limb ischemia. Thromb Res (2009) 0.75
[Not Available]. Duodecim (2007) 0.75
[Severe arterial thromboses associated with thrombophilia]. Duodecim (2003) 0.75
Topically administered macromolecular heparin proteoglycans inhibit thrombus growth in microvascular anastomoses. Thromb Haemost (2002) 0.75
[Dabigatran and emergency operation on a peritonitis patient]. Duodecim (2012) 0.75
Wall motion and perfusion analysis of transmyocardial laser revascularization. Scand Cardiovasc J (2003) 0.75
[Antithrombotic medication as prophylaxis of thromboembolism in surgery patients]. Duodecim (2004) 0.75
[Gamma-imaging of myocardial perfusion]. Duodecim (2005) 0.75
Successful treatment of mesenterial venous thrombosis with recombinant hirudin--a report of five cases. Thromb Res (2005) 0.75